aTyr Pharma stockholders approve doubling authorized shares to 85M

aTYR PHARMA INC

Stockholders approved increase in authorized common shares from 42.5M to 85,000,000.
Amendment to 2015 Stock Plan approved, increasing reserved shares by 2,000,000.
Amendment to 2015 ESPP approved, increasing reserved shares by 750,000 and per-employee limit to 2,500.
All three Class I director nominees elected (John Clarke, Paul Schimmel, Sara Zaknoen).
Ratification of Ernst & Young as auditor and advisory approval of executive compensation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.